Search

Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report.

Joint report by ECDC, EFSA, EMA, and OECD on antimicrobial resistance in the EU/EEA and a One Health response. Antimicrobial resistance remains a serious challenge for everyone, a silent pandemic that calls for a One Health response in the EU/EEA.

The results presented in this report are based on antimicrobial resistance (AMR) data from invasive isolates reported to the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2021 (data referring to 2020).

For 2020, twenty-nine countries (27 European Union (EU) Member States and two European Economic Area (EEA) countries - Iceland and Norway) reported data on antimicrobial consumption. Twenty-five countries reported data for both community and hospital consumption; two countries (Germany and Iceland) reported only community consumption, and two countries (Cyprus and Czechia) reported total consumption for both sectors combined.

Third joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA.

In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.